Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
30 participants
INTERVENTIONAL
2025-06-24
2026-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
S&B Heat Stress Pilot Protocols
NCT06094764
Validity of Humidity Ramp Protocols for Identifying Limits of Survivability in Heat-exposed Persons
NCT05963529
Tarp Assisted Cooling of Hyperthermic Individuals
NCT04095403
Heat Waves and the Elderly - Cooling Modalities
NCT05484739
Cooling Strategies for Older Adults in the Heat
NCT06349616
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To accomplish the aims of testing two active cooling interventions, the investigators plan to implement a case-cross over randomized control trial design at the work site conducted in partnership with an employer and with 30 workers at risk for hyperthermia. Over three sequential weeks, the investigators will measure rate of core temperature change (primary outcome). Secondary outcomes will include changes in kidney injury markers; changes in worker productivity; and worker acceptability of interventions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Heat Illness Prevention
Standard CAL-OSHA workplace heat illness prevention interventions, which require availability of cool, potable water; availability of shade when temperatures exceed 80F; and encouragement of rest for cool down breaks.
Standard Heat Illness Prevention Measures
Standard CAL-OSHA workplace heat illness prevention interventions, which require availability of cool, potable water; availability of shade when temperatures exceed 80F; and encouragement of rest for cool down breaks
Cooling bandana with Standard Heat Illness Prevention Measures
Provision of a bandana with slow-evaporation polymer for use during work, in addition to standard CAL-OSHA workplace heat illness prevention interventions
Standard Heat Illness Prevention Measures
Standard CAL-OSHA workplace heat illness prevention interventions, which require availability of cool, potable water; availability of shade when temperatures exceed 80F; and encouragement of rest for cool down breaks
Cooling bandana
Cooling bandana embedded with a polymer to slow evaporation
Cooling glove with standard Heat Illness Prevention
Provision of a glove with ability to circulate cool water, for use during breaks, in addition to standard CAL-OSHA workplace heat illness prevention interventions
Standard Heat Illness Prevention Measures
Standard CAL-OSHA workplace heat illness prevention interventions, which require availability of cool, potable water; availability of shade when temperatures exceed 80F; and encouragement of rest for cool down breaks
Cooling glove
Cooling glove with ability to circulate cool water interface with palmar skin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard Heat Illness Prevention Measures
Standard CAL-OSHA workplace heat illness prevention interventions, which require availability of cool, potable water; availability of shade when temperatures exceed 80F; and encouragement of rest for cool down breaks
Cooling bandana
Cooling bandana embedded with a polymer to slow evaporation
Cooling glove
Cooling glove with ability to circulate cool water interface with palmar skin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Anticipated to be working in the same job category for the duration of the study
3. Able to communicate in English or Spanish
Exclusion Criteria
2. Weight less than 40 kg
3. Inability to swallow pills
4. Known history of having a pacemaker or ICD
5. Pregnancy as determined by self report and confirmed on Day 1
6. Gastrointestinal disorders (e.g., gastroparesis, prior surgery on GI tract with the exception of appendectomy or cholecystectomy, diverticulosis or inflammatory bowel disease)
7. Plan for an elective MRI in the 7 days post last planned pill ingestion
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shuchi Anand
Associate Professor in Nephrology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shuchi Anand, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Julie Parsonnet, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
80246
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.